No Data
No Data
No Data
No Data
No Data
Xinhua Healthcare (600587): Driven by Innovation and Accelerating Old State-owned Enterprises to Revitalize New Vitality
Incident: The company released its 2023 annual report, achieving operating income of 10.012 billion yuan (+7.87%), net profit of 654 million yuan (+30.78%), and net profit of non-return to mother of 619 million yuan (+23)
海通證券Apr 13 00:00
Express News | The list of stocks that continue to grow after deducting non-net profit has been released
BreakingsApr 11 23:08
Investors Aren't Entirely Convinced By Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Earnings
With a price-to-earnings (or "P/E") ratio of 14.8x Shinva Medical Instrument Co.,Ltd. (SHSE:600587) may be sending very bullish signals at the moment, given that almost half of all companies in China
Simply Wall StApr 9 07:36
The medical device sector fluctuated and declined in the afternoon, and Xinhua Healthcare hit a halt
The medical device sector fluctuated and declined in the afternoon. Xinhua Medical hit a halt. Yangpu Medical fell by more than 10%, while Jianfan Biotech, Innotek, and Yirui Biotech had the highest declines.
Zhitong FinanceApr 8 13:32
Xinhua Healthcare (600587): Focus on the main business, consolidate competitiveness, optimize structure and improve quality
Incident: The company released its 2023 annual report. In 2023, it achieved total operating revenue of 10.01 billion yuan, an increase of 7.9% over the previous year; net profit to mother of 650 million yuan, an increase of 30.8% over the previous year; net profit of 620 million yuan after deducting non-return to mother.
西南證券Apr 3 00:00
Xinhua Healthcare (600587) 2023 Report Review: Product Structure Continues to Improve, and International Business Is Growing Rapidly
Matters: The company released its 2023 annual report, with revenue of 10.012 billion yuan (+7.87%), net profit to mother of 654 million yuan (+30.78%), net profit of 619 million yuan (+23.20) after deducting non-net profit
華創證券Apr 1 18:11
No Data
No Data